Acrivon Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Acrivon Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Acrivon Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Acrivon Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $36k | 20k | 1.81 |
| 2025-03-31 | $117k | 58k | 2.03 |
| 2024-12-31 | $1.4M | 238k | 6.02 |
| 2024-09-30 | $1.4M | 198k | 7.00 |
| 2024-06-30 | $141k | 24k | 5.80 |
| 2023-03-31 | $174k | 14k | 12.69 |
| 2022-12-31 | $447k | 39k | 11.52 |